AUS
NZ
UK
CA
USA
IND
Healthcare
Merck (MRK), Sanofi (SNY) raise profit guidance after solid Q3 results
October 28, 2021 09:17 AM PDT| By Ipsita SarkarHighlights Merck & Company, Inc’s (MRK) sales rose 20% YoY in Q3, FY21. Merck expects its adjusted annual profit to be between US$5.65 per share and US$5.70 per share. Sanofi (SNY) sales surged 10.1% YoY in Q3, FY21. Stocks of M.....
Bristol Myers (BMY), GlaxoSmithKline (GSK) post strong revenue growth
October 27, 2021 11:18 AM PDT| By Ipsita SarkarHighlights Bristol-Myers Squibb Company (NYSE: BMY) revenue surged 10% YoY to US$11.5 billion in Q3, FY21. BMY raised its low-end adjusted EPS guidance by US$0.05 for fiscal 2021. GlaxoSmithKline PLC (NYSE: GSK) sales surged 10% YoY in Q3, FY2.....
Thermo Fisher (TMO), Boston Scientific (BSX) lift guidance after Q3 results
October 27, 2021 09:23 AM PDT| By Ipsita SarkarHighlights Thermo Fisher Scientific Inc’s (NYSE: TMO) revenue increased by 9% YoY in Q3, FY21. TMO raised its revenue guidance for fiscal 2021 to US$37.1 billion. Boston Scientific Corp (NYSE: BSX) expects EPS in the range of US$0.21 to .....
Eli Lilly (LLY), Novartis (NVS) profits up on robust sales growth
October 26, 2021 09:07 AM PDT| By Ipsita SarkarHighlights Eli Lilly and Company (NYSE: LLY) posted Q3 revenue of US$6.773 billion, up 18% YoY. Novartis AG’s (NYSE: NVS) net income rose 43% YoY to US$2.8 billion on net sales of US$13.0 billion. LLY raises revenue forecast for 2021; NV.....
Abbott (ABT), Anthem (ANTM) stocks rise after upbeat revenue outlook
October 20, 2021 09:23 AM PDT| By Ipsita SarkarHighlights Abbott Laboratories’ (NYSE: ABT) third-quarter sales rose 23.4% to US$10.9 billion YoY. Abbott raised its full-year adjusted EPS guidance to between US$5.00 and US$5.10. Anthem, Inc’s (NYSE: ANTM) operating revenue jump.....
PROG, ADMP stocks jump after FDA approval, patent rights
October 18, 2021 05:12 PM PDT| By Sanjeeb BaruahHighlights Progenity, Inc. (NASDAQ: PROG) secured four patents for ingestible technologies from the US Patent and Trademark Office (USPTO). The PROG stock grew nearly 47% since the patent announcement on October 13. Adamis Pharmaceuticals Cor.....
Seven stocks to explore as demand for healthcare soars
October 15, 2021 06:15 PM PDT| By Ipsita SarkarHighlights CVS Health Corporation’s (NYSE: CVS) next ex-dividend date is Oct 21, 2021. Global Cord Blood Corporation’s (NYSE: CO) operating income was US$24.2 million in the June quarter of 2021. It added 19,673 new subscr.....
Why is the stock of gene-editing titan CRISPR hogging attention?
October 14, 2021 05:37 PM PDT| By Sanjeeb BaruahSwiss-American biotechnology company CRISPR Therapeutics (NASDAQ: CRSP) has been gaining significant attention in recent days. While the stock has seen several ups and downs this week, it appeared on firmer ground on Thursday after closing the sess.....
Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge
October 14, 2021 03:19 PM PDT| By Sanjeeb BaruahPharmacy chain operator Walgreens Boots Alliance Reports on Thursday reported a fourth-quarter profit of US$358 million after witnessing robust growth in the US and the UK markets. Walgreens’ net earnings from operations increased by 6.4% Yo.....
UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 11%
October 14, 2021 07:31 AM PDT| By Ipsita SarkarHighlights UnitedHealth Group (NYSE: UNH) declared third-quarter results on Thursday. The group served 146 million people across its businesses as of September 30, 2021. UNH posted revenue of US$72.3 billion and 23.5% return on equity in the t.....
Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approval
October 12, 2021 02:00 PM PDT| By Ipsita SarkarHighlights Nutriband Inc. (NASDAQ: NTRB) stock jumped on securing a lucrative manufacturing deal with San Diego-based Diomics for its Diocheck™ technology. Protara Therapeutics, Inc. (NASDAQ: TARA) climbed 11.41% after receiving FDA clear.....
CLOV, ADMS stocks up on rating upgrade, purchase deal
October 11, 2021 11:10 AM PDT| By Ipsita SarkarHighlights Stocks of Clover Health Investments, Corp. (NASDAQ: CLOV) and Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) were gaining traction on Monday. The Centers for Medicare and Medicaid Services (CMS) upgraded the CLOV stock to a 3.5-star rat.....
ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news
October 08, 2021 09:18 AM PDT| By Ipsita SarkarHighlights FDA has approved ChemoCentryx's drug Avacopan, to be sold under the brand name Tavneos. A Duke University study showed Vaxart's oral drug is more effective in reducing SARS-CoV-2 transmission. Vaxart, Inc. (NASDAQ: VXRT) stock.....
Voyager Therapeutics (VYGR) stock jumps 56% on Pfizer licensing deal
October 06, 2021 03:29 PM PDT| By Sanjeeb BaruahHighlights Voyager Therapeutics, Inc. (NASDAQ: VYGR) sealed a license option deal with Pfizer worth around US$630 million. Pfizer may exercise the option to use Voyager’s RNA-driven TRACERTM screening technology for developing its gene th.....
Ocugen (OCGN) & Aditxt (ADTX): Two trending biotech stocks
October 05, 2021 12:34 PM PDT| By Team Kalkine MediaHighlights Ocugen, Inc. (NASDAQ: OCGN) has entered into a development and supply agreement with Bharat Biotech for a Covid-19 vaccine candidate. Aditxt, Inc. (NASDAQ: ADTX) has entered into a transaction agreement for acquiring a subsidiary of .....
Xenon (XENE), OpGen (OPGN) stocks soar on drug results, FDA approval
October 04, 2021 04:12 PM PDT| By Team Kalkine MediaHighlights Xenon Pharmaceuticals Inc. (NASDAQ: XENE) achieved positive topline results from phase-2b clinical trials of‘XEN1101’ for treating focal epilepsy. OpGen, Inc. (NASDAQ: OPGN) got 510(k) received FDA clearance to mark.....
ALZN & AEZS: Two trending biotechnology stocks on Friday
October 01, 2021 10:56 AM PDT| By Ipsita SarkarHighlights Aeterna Zentaris Inc. (NASDAQ: AEZS) develops diagnostic and therapeutic tests. Alzamend Neuro, Inc. (NASDAQ: ALZN) develops treatment for neurodegenerative diseases and psychiatric disorders. Aeterna has been placed on NASDAQ.....
Atea (AVIR) & Catalyst (CPRX): Two trending healthcare stocks today
September 30, 2021 01:48 PM PDT| By Team Kalkine MediaHighlights Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) stocks surged 11.24 percent to US$35.74 on September 30. Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) jumped 7.97 percent to US$5.42 at 1.50 pm on Thursday. CPRX received a favorable court .....
Why did Moderna (MRNA), Altimmune (ALT) stocks nosedive today?
September 28, 2021 04:27 PM PDT| By Sanjeeb BaruahHighlights Altimmune, Inc. (Nasdaq: ALT) stocks fell despite positive results from the clinical trial of its medicine for obese people. Moderna, Inc. (Nasdaq: MRNA) stock declined after recent comments from CEO Stéphane Bancel on the pan.....
Explore seven healthcare stocks that are under US$50
September 28, 2021 12:59 PM PDT| By Sanjeeb BaruahHighlights Halozyme Therapeutics’ (NASDAQ: HALO) GAAP net income was US$91.5 million in Q2, 2021, compared to US$25.8 million in Q2, 2020. Adaptive Biotechnologies Corporation’s (Nasdaq: ADPT) revenue for Q2, 2021, was US$38.5 milli.....
